1,470
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Limitations of current monoclonal antibodies for plaque-type psoriasis and an outlook for the future

, , &
Pages 605-607 | Received 25 Oct 2017, Accepted 18 May 2018, Published online: 30 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Elisa Camela, Luca Potestio, Angelo Ruggiero, Sonia Sofia Ocampo-Garza, Gabriella Fabbrocini & Matteo Megna. (2022) Towards Personalized Medicine in Psoriasis: Current Progress. Psoriasis: Targets and Therapy 12, pages 231-250.
Read now
M Galluzzo, S D’Adamio, A Massaro, A Piccolo, L Bianchi & M Talamonti. (2019) Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date. Clinical, Cosmetic and Investigational Dermatology 12, pages 311-321.
Read now
Matteo Megna, Luisa Di Costanzo, Giuseppe Argenziano, Anna Balato, Paola Colasanti, Francesco Cusano, Antonia G. Galluccio, Alessio Gambardella, Serena Lembo, Raffaele Mozzillo, Genoveffa Scotto Di Luzio, Gabriella Fabbrocini & Nicola Balato. (2019) Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study. Expert Opinion on Biological Therapy 19:8, pages 855-861.
Read now
M. Galluzzo, S. D’Adamio, E. Campione, L. Bianchi & M. Talamonti. (2018) A safety evaluation of guselkumab for the treatment of psoriasis. Expert Opinion on Drug Safety 17:7, pages 741-751.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.